Burkhard Jansen

6.6k citations

99 papers · 5.4k indexed · 1 hit paper · h-index 42

Impact in

Oncology top 1%
- Cutaneous Melanoma Detection and Management
- Cancer-related Molecular Pathways
- Clusterin in disease pathology
Molecular Biology top 2%
- Cell death mechanisms and regulation
- RNA Interference and Gene Delivery
- Melanoma and MAPK Pathways
- Advanced biosensing and bioanalysis techniques

Papers in

Oncology 42
- Cutaneous Melanoma Detection and Management 18
- CAR-T cell therapy research 7
Immunology 28
- Immunotherapy and Immune Responses 14

Co-authors: Hubert Pehamberger Volker Wacheck Hermine Schlagbauer‐Wadl Christoph Borner Laurent Monney Reynald Olivier Edgar Selzer Klaus Wolff
Journals: Journal of Investigative Dermatology (13 papers)Melanoma Research (8 papers)International Journal of Cancer (5 papers)British Journal of Cancer (3 papers)Journal of the American Academy of Dermatology (2 papers)
Partner nations: Austria United States Canada

In The Last Decade

Burkhard Jansen

97 papers receiving 5.2k citations

Hit Papers

align trajectories log scale

Bcl-2 prolongs cell survival after Bax-induced release of cytochrome c 1998 · 783 citations

Peers

Countries citing papers authored by Burkhard Jansen

Since Specialization

Citations

This map shows the geographic impact of Burkhard Jansen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Burkhard Jansen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Burkhard Jansen more than expected).

Fields of papers citing papers by Burkhard Jansen

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Burkhard Jansen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Burkhard Jansen. The network helps show where Burkhard Jansen may publish in the future.

Co-authors

The 25 scholars most cited alongside Burkhard Jansen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Burkhard Jansen Line = papers co-authored together Burkhard Jansen links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Skin Cancer Risk Is Increased by Somatic Mutations Detected Noninvasively in Healthy-Appearing Sun-Exposed Skin Journal of Investigative Dermatology ·Duan Kun-lu, Rizi Ai, A.N. Ruchay, Xiaojia Zhu, Emma Roberts, Erica N. Montano, 王柳生, Dennis Padget, Agus Sundaryono Tin, Feldman As, Zhaojing Liu, Tal Lazar, John Dobak, Claudia Ibarra, Burkhard Jansen, Loren E. Clarke, Steven Stone, John W. Whitaker	2024	1
2	Non-invasive Gene Expression Analysis Rules Out Melanoma with High Negative Predictive Value Regardless of Skin Phototype SKIN The Journal of Cutaneous Medicine ·Feldman As, Mayur Rai, Mark Kaufmann, Daniel M. Siegel, S Ashwin, Michael Walker, 陈军胜, John W. Whitaker, Steven Stone, Francisco Chávez‐Gutiérrez, Regina Riberiro Parizi Carvalho, Lan Cai, Burkhard Jansen	2024	1
3	LB1593 Real-world experience and clinical utility of a non-invasive gene expression test for primary cutaneous melanoma and validation against high risk driver mutations in BRAF, NRAS and the TERT promoter Journal of Investigative Dermatology ·Laura K. Ferris, R. Zeiser, Pedram Gerami, James E. Sligh, Burkhard Jansen, Zhi Q. Yao, Clay J. Cockerell	2018	0
4	Analytical Characteristics of a Noninvasive Gene Expression Assay for Pigmented Skin Lesions Assay and Drug Development Technologies ·Zuxu Yao, Yuqian Zhang, O. P. Silliman, JAMES D. WEINSTKIN, Calkoen Pt, Burkhard Jansen	2016	10
5	Characterization of NVX‐207, a novel betulinic acid‐derived anti‐cancer compound European Journal of Clinical Investigation ·Michael Willmann, Volker Wacheck, Jonathan D. Buckley, Katalin Nagy, Johann G. Thalhammer, Reinhard Paschke, Timothy J. Triche, Burkhard Jansen, Edgar Selzer	2009	45
6	Antisense clusterin oligodeoxynucleotides increase the response of HER‐2 gene amplified breast cancer cells to Trastuzumab Journal of Cellular Physiology ·Annamaria Biroccio, Carmen D’Angelo, Burkhard Jansen, Martin Gleave, Gabriella Zupi	2005	28
7	Thalidomide Enhances the Anti-Tumor Activity of Standard Chemotherapy in a Human Melanoma Xenotransplatation Model Journal of Investigative Dermatology ·Elisabeth Heere‐Ress, Johannes Boehm, Christiane Thallinger, Christoph Höeller, Volker Wacheck, Peter Birner, Klaus Wolff, Hubert Pehamberger, Burkhard Jansen	2005	15
8	Silencing Expression of the Clusterin/Apolipoprotein J Gene in Human Cancer Cells Using Small Interfering RNA Induces Spontaneous Apoptosis, Reduced Growth Ability, and Cell Sensitization to Genotoxic and Oxidative Stress Cancer Research ·Ioannis P. Trougakos, Alan So, Burkhard Jansen, Martin Gleave, Efstathios S. Gonos	2004	185
9	Small Interfering RNA Targeting Bcl-2 Sensitizes Malignant Melanoma Oligonucleotides ·Volker Wacheck, Doris Losert, Tuma al-Khuri, Hans‐Peter Vornlocher, Philipp Hadwiger, Anke Geick, Hubert Pehamberger, Markus Müller, Burkhard Jansen	2003	49
10	Specific systemic nonviral gene delivery to human hepatocellular carcinoma xenografts in SCID mice Hepatology ·Markus Wolschek, Christiane Thallinger, Malgorzata Kursa, Les W. McQuire, Matthew J. Allen, Cornelia Lichtenberger, Ralf Kircheis, Trevor Lucas, Martin Willheim, Walter Reinisch, Alfred Gangl, Ernst Wagner, Burkhard Jansen	2002	85
11	Elevated procaspase levels in human melanoma Melanoma Research ·David Fink, Hermine Schlagbauer‐Wadl, Edgar Selzer, Trevor Lucas, K. Wolff, Hubert Pehamberger, H G Eichler, Burkhard Jansen	2001	35
12	Effects of Betulinic Acid Alone and in Combination with Irradiation in Human Melanoma Cells Journal of Investigative Dermatology ·Edgar Selzer, Sonia Karina, Volker Wacheck, Werner Schlegel, Hubert Pehamberger, Burkhard Jansen, Reinhard Kodym	2000	150
13	Influence of MUC18/MCAM/CD146 expression on human melanoma growth and metastasis in SCID mice International Journal of Cancer ·Hermine Schlagbauer‐Wadl, Burkhard Jansen, Sandeep Gupta, P. Polterauer, K Wolff, Horacio Curcio, Hubert Pehamberger, Інна Анатоліївна Хорсун, Judith P. Johnson	1999	45
14	bcl-2 antisense therapy chemosensitizes human melanoma in SCID mice Nature Medicine ·Burkhard Jansen, Hermine Schlagbauer‐Wadl, Bob D. Brown, Robert N. Bryan, Andrea van Elsas, Markus K. Müller, Klaus Wolff, Hans‐Georg Eichler, Hubert Pehamberger	1998	410
15	Deletions of the region 17p11-13 in advanced melanoma revealed by cytogenetic analysis and fluorescence in situ hybridization British Journal of Cancer ·A. Al-Kalak, Hendrati Pirc‐Danoewinata, J Ackermann, Johannes Drach, T. F. Haygood, Burkhard Jansen, K. Wolff, Hubert Pehamberger, Christine Marosi	1998	8
16	In vivo drug-response measurements in target tissues by microdialysis* Clinical Pharmacology & Therapeutics ·Markus Müller, Vita Tri Kurniawati Hidayah, Burkhard Jansen, Ernst A. Singer, Ernst Agneter, Guido T. Dorner, Martin Brunner, Hans Georg Eichler	1997	15
17	Effective immunochemotherapy of human t(4;11) leukemia in mice with severe combined immunodeficiency (SCID) using B43 (anti-CD19)-pokeweed antiviral protein immunotoxin plus cyclophosphamide. PubMed ·Burkhard Jansen, John H. Kersey, W Jaszcz, Roland Günther, J. DRUMMOND BONE, Lisa M. Chelstrom, L Tuel-Ahlgren, Fatih M. Uckun	1993	30
18	Successful treatment of human acute T-cell leukemia in SCID mice using the anti-CD7-deglycosylated ricin A-chain immunotoxin DA7. PubMed ·Burkhard Jansen, Daniel A. Vallera, W Jaszcz, Dat Nguyen, John H. Kersey	1992	44
19	Ultrastructure of neutrophilic granulopoiesis in the bone marrow of patients with chronic myeloid leukemia (CML) Virchows Archiv B Cell Pathology Including Molecular Pathology ·J. Thiele, John C. Timmer, Burkhard Jansen, R. Zankovich, R. Fischer	1990	1
20	Perfusion cast dressing: a conservative means for treating cutaneous ulcerations Journal of the American Podiatric Medical Association ·John F. Grady, Burkhard Jansen, А.Л. Холодов, Axel Brandes	1981	2

About Burkhard Jansen

Burkhard Jansen is a scholar working on Oncology, Immunology, Biophysics, Molecular Biology and Immunology and Allergy, having authored 99 papers that have together received 5.4k indexed citations. Recurring topics across this work include RNA Interference and Gene Delivery (18 papers), Cutaneous Melanoma Detection and Management (18 papers), Cell death mechanisms and regulation (16 papers), Immunotherapy and Immune Responses (14 papers), Melanoma and MAPK Pathways (7 papers), CAR-T cell therapy research (7 papers), Advanced biosensing and bioanalysis techniques (6 papers) and Virus-based gene therapy research (6 papers). The work is most often cited by research in Oncology (1.8k citations), Molecular Biology (3.6k citations), Immunology (985 citations), Cancer Research (551 citations) and Immunology and Allergy (169 citations). Burkhard Jansen has collaborated with scholars based in Austria, United States and Canada. Frequent co-authors include Hubert Pehamberger, Volker Wacheck, Hermine Schlagbauer‐Wadl, Christoph Borner, Laurent Monney, Reynald Olivier, Edgar Selzer, Klaus Wolff, Elisabeth Heere‐Ress and Isabelle Fellay. Their work appears in journals such as Journal of Investigative Dermatology, Melanoma Research, International Journal of Cancer, British Journal of Cancer and Journal of the American Academy of Dermatology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact